$CLFD
Clearfield, Inc.

2021 Q1 Form 10-Q Financial Statement

#000117184321002840 Filed on April 28, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1 2019 Q4
Revenue $29.69M $20.41M $19.38M
YoY Change 45.49% 6.94% -3.54%
Cost Of Revenue $16.75M $12.26M $11.65M
YoY Change 36.66% 1.64% -4.05%
Gross Profit $12.94M $8.151M $7.728M
YoY Change 58.77% 16.03% -2.76%
Gross Profit Margin 43.59% 39.94% 39.88%
Selling, General & Admin $8.490M $7.431M $7.327M
YoY Change 14.25% 10.46% 8.13%
% of Gross Profit 65.6% 91.17% 94.81%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $570.0K $600.0K $607.0K
YoY Change -5.0% 13.21% 14.65%
% of Gross Profit 4.4% 7.36% 7.85%
Operating Expenses $8.490M $7.431M $7.327M
YoY Change 14.25% 10.46% 8.13%
Operating Profit $4.452M $720.2K $400.9K
YoY Change 518.19% 142.08% -65.76%
Interest Expense $120.0K $220.0K $220.0K
YoY Change -45.45% 29.41% 57.14%
% of Operating Profit 2.7% 30.55% 54.87%
Other Income/Expense, Net
YoY Change
Pretax Income $4.575M $937.9K $624.2K
YoY Change 387.79% 100.86% -52.21%
Income Tax $935.0K $190.0K $123.0K
% Of Pretax Income 20.44% 20.26% 19.71%
Net Earnings $3.640M $747.9K $501.2K
YoY Change 386.7% 103.26% -50.38%
Net Earnings / Revenue 12.26% 3.66% 2.59%
Basic Earnings Per Share $0.27 $0.05 $0.04
Diluted Earnings Per Share $0.27 $0.05 $0.04
COMMON SHARES
Basic Shares Outstanding 13.73M 13.52M 13.51M
Diluted Shares Outstanding 13.78M 13.52M 13.62M

Balance Sheet

Concept 2021 Q1 2020 Q1 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $32.30M $23.30M $25.10M
YoY Change 38.63% -6.8% 5.46%
Cash & Equivalents $22.34M $8.576M $10.59M
Short-Term Investments $10.00M $14.70M $14.50M
Other Short-Term Assets $717.6K $687.9K $825.1K
YoY Change 4.32% -45.13% 26.31%
Inventory $14.63M $11.69M $10.63M
Prepaid Expenses
Receivables $13.20M $8.070M $7.026M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $60.84M $43.73M $43.59M
YoY Change 39.12% 0.6% 3.06%
LONG-TERM ASSETS
Property, Plant & Equipment $4.750M $5.564M $5.682M
YoY Change -14.64% 26.11% 23.73%
Goodwill $4.709M $4.709M $4.709M
YoY Change 0.0% 0.0% 0.0%
Intangibles $4.793M $4.969M $5.060M
YoY Change -3.54% -6.29% -5.99%
Long-Term Investments $25.60M $25.10M $21.70M
YoY Change 1.99% 34.95% 18.58%
Other Assets $262.4K $194.2K $202.5K
YoY Change 35.11% -4.12% -5.32%
Total Long-Term Assets $42.98M $43.48M $39.57M
YoY Change -1.14% 30.96% 19.23%
TOTAL ASSETS
Total Short-Term Assets $60.84M $43.73M $43.59M
Total Long-Term Assets $42.98M $43.48M $39.57M
Total Assets $103.8M $87.21M $83.16M
YoY Change 19.05% 13.74% 10.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.012M $3.874M $2.316M
YoY Change 29.39% 64.66% 20.74%
Accrued Expenses $492.8K $327.4K $327.2K
YoY Change 50.52% 735.22% -62.09%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $11.89M $8.388M $5.280M
YoY Change 41.74% 74.33% 15.98%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.100M $2.500M $1.900M
YoY Change -16.0% 733.33% 533.33%
Total Long-Term Liabilities $2.081M $2.571M $2.042M
YoY Change -19.06% 607.3% 453.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.89M $8.388M $5.280M
Total Long-Term Liabilities $2.081M $2.571M $2.042M
Total Liabilities $13.97M $10.96M $7.322M
YoY Change 27.48% 111.76% 48.78%
SHAREHOLDERS EQUITY
Retained Earnings $31.92M $19.07M $18.32M
YoY Change 67.37% 30.32% 28.44%
Common Stock $137.3K $136.3K $136.6K
YoY Change 0.77% -0.3% -0.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $89.85M $76.25M $75.84M
YoY Change
Total Liabilities & Shareholders Equity $103.8M $87.21M $83.16M
YoY Change 19.05% 13.74% 10.17%

Cashflow Statement

Concept 2021 Q1 2020 Q1 2019 Q4
OPERATING ACTIVITIES
Net Income $3.640M $747.9K $501.2K
YoY Change 386.7% 103.26% -50.38%
Depreciation, Depletion And Amortization $570.0K $600.0K $607.0K
YoY Change -5.0% 13.21% 14.65%
Cash From Operating Activities $3.980M $2.400M -$99.83K
YoY Change 65.83% 46.34% -101.46%
INVESTING ACTIVITIES
Capital Expenditures -$300.0K -$390.0K $788.5K
YoY Change -23.08% 44.44% 185.06%
Acquisitions
YoY Change
Other Investing Activities -$260.0K -$3.590M $1.230M
YoY Change -92.76% -59.3% 925.0%
Cash From Investing Activities -$560.0K -$3.980M $438.5K
YoY Change -85.93% -56.26% -383.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $169.7K
YoY Change -216.25%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -240.0K -430.0K 166.4K
YoY Change -44.19% 19.49%
NET CHANGE
Cash From Operating Activities 3.980M 2.400M -99.83K
Cash From Investing Activities -560.0K -3.980M 438.5K
Cash From Financing Activities -240.0K -430.0K 166.4K
Net Change In Cash 3.180M -2.010M 505.1K
YoY Change -258.21% -73.06% -92.58%
FREE CASH FLOW
Cash From Operating Activities $3.980M $2.400M -$99.83K
Capital Expenditures -$300.0K -$390.0K $788.5K
Free Cash Flow $4.280M $2.790M -$888.3K
YoY Change 53.41% 46.07% -113.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 clfd Assets Noncurrent Excluding Property Plant And Equipment
AssetsNoncurrentExcludingPropertyPlantAndEquipment
38231351
CY2020Q3 clfd Assets Noncurrent Excluding Property Plant And Equipment
AssetsNoncurrentExcludingPropertyPlantAndEquipment
37821802
clfd Increase Decrease In Accounts Payable Accrued Expenses And Deferred Rent
IncreaseDecreaseInAccountsPayableAccruedExpensesAndDeferredRent
1239733
clfd Increase Decrease In Accounts Payable Accrued Expenses And Deferred Rent
IncreaseDecreaseInAccountsPayableAccruedExpensesAndDeferredRent
1091431
clfd Issuance Of Common Stock Funded Through Shares Sold To Company
IssuanceOfCommonStockFundedThroughSharesSoldToCompany
1269414
clfd Issuance Of Common Stock Funded Through Shares Sold To Company
IssuanceOfCommonStockFundedThroughSharesSoldToCompany
7737
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
623235
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
87937
CY2021Q1 clfd Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
CY2021Q1 clfd Number Of Patents Granted
NumberOfPatentsGranted
26
clfd Payments For Proceeds From Tax Withholding Stock Options Exercised
PaymentsForProceedsFromTaxWithholdingStockOptionsExercised
456124
clfd Payments For Proceeds From Tax Withholding Stock Options Exercised
PaymentsForProceedsFromTaxWithholdingStockOptionsExercised
-2582
CY2021Q1 clfd Revenues Percent
RevenuesPercent
1
CY2020Q1 clfd Revenues Percent
RevenuesPercent
1
clfd Revenues Percent
RevenuesPercent
1
clfd Revenues Percent
RevenuesPercent
1
CY2021Q1 clfd Stock Issued During Period Value Stock Options Exercised Net Of Shares Exchanged For Payment
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesExchangedForPayment
-193654
CY2020Q1 clfd Stock Issued During Period Value Stock Options Exercised Net Of Shares Exchanged For Payment
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesExchangedForPayment
2
clfd Stock Issued During Period Value Stock Options Exercised Net Of Shares Exchanged For Payment
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesExchangedForPayment
-456124
clfd Stock Issued During Period Value Stock Options Exercised Net Of Shares Exchanged For Payment
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesExchangedForPayment
2582
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
5011965
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3689587
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13195295
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10496672
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
55641
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
492758
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1202753
CY2021Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
5496056
CY2020Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
4856885
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
57794061
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
57502905
CY2021Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
43261
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
54208
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
5803
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
334178
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
87937
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
623235
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
328523
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
334178
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
328523
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
79473
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
136500
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
289085
CY2021Q1 us-gaap Assets
Assets
103817503
CY2020Q3 us-gaap Assets
Assets
95297430
CY2021Q1 us-gaap Assets Current
AssetsCurrent
60836622
CY2020Q3 us-gaap Assets Current
AssetsCurrent
52522809
us-gaap Basis Of Accounting
BasisOfAccounting
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt 0; font-size: 10pt"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font: inherit;">1.</div> Basis of Presentation</div></div> <div style=" margin: 0pt 0; font-size: 10pt">&nbsp;</div> <div style=" margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in"><div style="display: inline; color: black">The accompanying (a) condensed balance sheet as of <div style="display: inline; font-style: italic; font: inherit;"> September 30, 2020, </div>which has been derived from audited financial statements, and (b) unaudited interim condensed financial statements as of and for the <div style="display: inline; font-style: italic; font: inherit;">three</div> and <div style="display: inline; font-style: italic; font: inherit;">six</div> months ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2021 </div>have been prepared by Clearfield, Inc. (the &#x201c;Company&#x201d;) in accordance with accounting principles generally accepted in the United States of America for interim financial information, pursuant to the rules and regulations of the Securities and Exchange Commission. Pursuant to these rules and regulations, certain financial information and footnote disclosures normally included in the financial statements have been condensed or omitted. However, in the opinion of management, the financial statements include all adjustments, consisting of normal recurring accruals, necessary for a fair presentation of the financial position, results of operations and cash flows of the interim periods presented. </div>Operating results for the interim periods presented are <div style="display: inline; font-style: italic; font: inherit;">not</div> necessarily indicative of results to be expected for the full year or for any other interim period, due to variability in customer purchasing patterns and seasonal, operating and other factors. <div style="display: inline; color: black">These condensed financial statements should be read in conjunction with the financial statements and notes thereto included in the Company's Annual Report on Form <div style="display: inline; font-style: italic; font: inherit;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font: inherit;"> September 30, 2020.</div></div></div> <div style=" margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</div> <div style=" margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">In preparation of the Company's financial statements, management is required to make estimates and assumptions that affect reported amounts of assets and liabilities and related revenues and expenses during the reporting periods. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates.</div> <div style=" margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</div> <div style=" margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">For the purposes of comparability, certain prior period amounts have been reclassified to conform to current period classification. There was <div style="display: inline; font-style: italic; font: inherit;">no</div> impact to prior period net income or shareholders' equity.</div> <div style=" margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</div> <div style=" margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in"><div style="display: inline; font-weight: bold;">New Accounting Pronouncements</div></div> <div style=" margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">In <div style="display: inline; font-style: italic; font: inherit;"> January 2017, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font: inherit;">2017</div>-<div style="display: inline; font-style: italic; font: inherit;">04,</div> Intangibles-Goodwill, which offers amended guidance to simplify the accounting for goodwill impairment by removing Step <div style="display: inline; font-style: italic; font: inherit;">2</div> of the goodwill impairment test. A goodwill impairment will now be measured as the amount by which a reporting unit's carrying value exceeds its fair value, limited to the amount of goodwill allocated to that reporting unit. This guidance is to be applied on a prospective basis effective for the Company's interim and annual periods beginning after <div style="display: inline; font-style: italic; font: inherit;"> December 15, 2019. </div>The new guidance is effective for the Company beginning in the <div style="display: inline; font-style: italic; font: inherit;">first</div> quarter of fiscal <div style="display: inline; font-style: italic; font: inherit;">2021.</div> The adoption of ASU <div style="display: inline; font-style: italic; font: inherit;">2017</div>-<div style="display: inline; font-style: italic; font: inherit;">04</div> in the <div style="display: inline; font-style: italic; font: inherit;">first</div> quarter of fiscal <div style="display: inline; font-style: italic; font: inherit;">2021</div> did <div style="display: inline; font-style: italic; font: inherit;">not</div> have a material impact on the Company's financial statements.</div> <div style=" margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</div> <div style=" margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">In <div style="display: inline; font-style: italic; font: inherit;"> June 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font: inherit;">2016</div>-<div style="display: inline; font-style: italic; font: inherit;">13,</div> Measurement of Credit Losses on Financial Instruments. In <div style="display: inline; font-style: italic; font: inherit;"> November 2018, </div>the FASB issued update ASU <div style="display: inline; font-style: italic; font: inherit;">2018</div>-<div style="display: inline; font-style: italic; font: inherit;">19</div> that clarifies the scope of the standard in the amendments in ASU <div style="display: inline; font-style: italic; font: inherit;">2016</div>-<div style="display: inline; font-style: italic; font: inherit;">13.</div> This guidance introduces a new model for recognizing credit losses on financial instruments based on an estimate of current expected credit losses. Financial instruments impacted include accounts receivable, trade receivables, other financial assets measured at amortized cost and other off-balance sheet credit exposures. The new guidance is effective for the Company beginning in the <div style="display: inline; font-style: italic; font: inherit;">first</div> quarter of fiscal <div style="display: inline; font-style: italic; font: inherit;">2023,</div> with early adoption permitted. The Company is evaluating the impact of the adoption of ASU <div style="display: inline; font-style: italic; font: inherit;">2016</div>-<div style="display: inline; font-style: italic; font: inherit;">13</div> on our financial statements.</div></div>
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22338721
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16449636
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16449636
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10081721
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22338721
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8575556
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5889085
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1506165
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13732806
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13649962
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13732806
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13649962
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
137328
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
16750354
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
12257076
us-gaap Cost Of Revenue
CostOfRevenue
32473256
us-gaap Cost Of Revenue
CostOfRevenue
23907532
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
178118
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
178118
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1139261
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1210961
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.50
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.50
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.204
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.192
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.203
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.2
CY2021Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
3182923
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y146D
CY2021Q1 us-gaap Goodwill
Goodwill
4708511
CY2020Q3 us-gaap Goodwill
Goodwill
4708511
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q1 us-gaap Gross Profit
GrossProfit
12941580
CY2020Q1 us-gaap Gross Profit
GrossProfit
8151433
us-gaap Gross Profit
GrossProfit
24310825
us-gaap Gross Profit
GrossProfit
15878968
CY2021Q1 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
35522831
CY2020Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
35725527
CY2021Q1 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
25565000
CY2020Q3 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
25143000
CY2021Q1 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
9957831
CY2020Q3 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
10582527
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4574784
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
937897
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
8422223
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1562055
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
935000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1619000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
190000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
313000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2331002
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
355657
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2908235
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1049108
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
218638
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2675123
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
188542
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-98010
CY2021Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
49629
CY2020Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
26956
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
55066
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4793137
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4986216
CY2021Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1541111
CY2020Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2048514
CY2021Q1 us-gaap Inventory Gross
InventoryGross
15664588
CY2020Q3 us-gaap Inventory Gross
InventoryGross
15368669
CY2021Q1 us-gaap Inventory Net
InventoryNet
14627176
CY2020Q3 us-gaap Inventory Net
InventoryNet
14408538
CY2021Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
11932008
CY2020Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
12287134
CY2021Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1037412
CY2020Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
960131
CY2021Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
2191469
CY2020Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
1033021
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
123324
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
217725
us-gaap Investment Income Interest
InvestmentIncomeInterest
257055
us-gaap Investment Income Interest
InvestmentIncomeInterest
440968
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3150520
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
986844
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
217552
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
516725
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
943682
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
485717
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
182281
CY2021Q1 us-gaap Liabilities
Liabilities
13969018
CY2020Q3 us-gaap Liabilities
Liabilities
12544152
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
103817503
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
95297430
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
11888456
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
10414809
CY2021Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2080562
CY2020Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2129343
CY2021Q1 us-gaap Long Term Investments
LongTermInvestments
25565000
CY2020Q3 us-gaap Long Term Investments
LongTermInvestments
25143000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-331251
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-262223
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-479313
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3540266
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6699649
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2296324
us-gaap Net Income Loss
NetIncomeLoss
6803223
us-gaap Net Income Loss
NetIncomeLoss
1249055
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
3639784
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
747897
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
4451460
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
720172
us-gaap Operating Income Loss
OperatingIncomeLoss
8165168
us-gaap Operating Income Loss
OperatingIncomeLoss
1121087
CY2021Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
307794
CY2020Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
274272
us-gaap Operating Lease Expense
OperatingLeaseExpense
616128
us-gaap Operating Lease Expense
OperatingLeaseExpense
516266
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
2968239
us-gaap Operating Lease Payments
OperatingLeasePayments
336655
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2724233
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2539100
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.034
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0348
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
887677
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
665584
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2080562
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2129343
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
240066
us-gaap Operating Lease Payments
OperatingLeasePayments
479801
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
168815
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y120D
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y284D
CY2021Q1 us-gaap Other Assets Current
OtherAssetsCurrent
717599
CY2020Q3 us-gaap Other Assets Current
OtherAssetsCurrent
585436
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
262352
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
266857
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
428654
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
54208
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5803
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
6448304
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
19076930
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
682009
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1183336
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
179081
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
169652
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
6651000
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
16720000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4749530
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4952819
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
209612
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
31917096
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
25113873
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29691934
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20408509
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
56784081
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
39786500
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8490120
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7431261
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16145657
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14757881
us-gaap Share Based Compensation
ShareBasedCompensation
623235
us-gaap Share Based Compensation
ShareBasedCompensation
328523
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y284D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.469
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0024
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
25309
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
13.89
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
105089
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
116600
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
890093
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
337100
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
315080
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.48
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.13
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
12.47
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
23.74
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12.43
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P5Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P5Y284D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y288D
CY2021Q1 us-gaap Short Term Investments
ShortTermInvestments
9957831
CY2020Q3 us-gaap Short Term Investments
ShortTermInvestments
10582527
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
101800
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
179081
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
169652
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
428654
CY2020Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
428654
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
89848485
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
82753278
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
86111438
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
75841560
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
76248742
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
74933387
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13779779
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13521172
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13738090
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13571674
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13730150
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13521172
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13711135
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13516608

Files In Submission

Name View Source Status
0001171843-21-002840-index-headers.html Edgar Link pending
0001171843-21-002840-index.html Edgar Link pending
0001171843-21-002840.txt Edgar Link pending
0001171843-21-002840-xbrl.zip Edgar Link pending
clfd-20210331.xml Edgar Link completed
clfd-20210331.xsd Edgar Link pending
clfd-20210331_cal.xml Edgar Link unprocessable
clfd-20210331_def.xml Edgar Link unprocessable
clfd-20210331_lab.xml Edgar Link unprocessable
clfd-20210331_pre.xml Edgar Link unprocessable
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_321.htm Edgar Link pending
f10q_042821p.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending